Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Examining social media could allow researchers an avenue to down the nation. Researchers have developed an online interactive platform that measures the “caloric content” of the nation’s social media posts, revealing eating habits by state.
The latest National Health Interview Survey figures on health coverage show the number of people without health insurance fell to a new low through the first nine months of 2016.
A review of 21 studies including more than 20,000 women found a 25 percent improved rate of patient outcomes in women participating in obstetrics and gynecology clinical trial when compared to those not participating.
Joe Kiani, CEO of patient monitoring tech company Masimo in Irvine, California, is pushing for medical device and electronic health record manufacturers to open up their code to allow their devices to talk to each other in the hospital.
According to a review released by the California Department of Managed Health Care (DMHC), 90 percent of California insurer reports on which providers were in their network contained inaccurate information.
Healthcare systems, hospitals and healthcare entities are more and more discovering their needs for an enterprise imaging (EI) strategy. As we are learning, imaging markets have been experiencing explosive growth due to advances in functional imaging technology and exploration of molecular imaging targets for diagnosis and therapy.
Researchers at State University of New York at Binghamton have developed a model kidney to show the inner working of the organ during different treatments to identify possible new solutions.
Effective communication is a pillar of achieving the best healthcare. With the large array of languages spoken in the United States, English can be a struggle. Healthcare providers are looking for an easier, more effective way to reach patients in their primary tongue.
Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.